Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gina Martin

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Journal of Drugs in Dermatology : JDD|June 24, 2020
New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric AnalysisLawrence F Eichenfield, Emil A Tanghetti, Eric Guenin, et al.
International Journal of Environmental Research and Public Health|August 26, 2022
Measurement Invariance of the WHO-5 Well-Being Index: Evidence from 15 European CountriesAlina Cosma, András Költő, Yekaterina Chzhen, et al.
The American Journal on Addictions|February 19, 2013
Alcohol and drug use as predictors of intentional injuries in two emergency departments in British ColumbiaCheryl J Cherpitel, Gina Martin, Scott Macdonald, et al.
Journal of Health Care for the Poor and Underserved|May 17, 2016
'Our only resource': Perspectives and Recommendations of Rural African American Youth on Adapting Sexual Health and Risk Reduction InterventionsRachel Hallum-Montes, Luella Rhodes, Cassandra Malone, et al.
Journal of Drugs in Dermatology : JDD|December 27, 2018
Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque PsoriasisLinda Stein Gold, Jerry Bagel, Mark Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|October 5, 2019
Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower ExtremitiesNeal D. Bhatia, Tracey C. Vlahovic, Lawrence G. Green, et al.
Children (Basel, Switzerland)|November 20, 2020
Examining Factors of Accelerometer-Measured Sedentary Time in a Sample of Rural Canadian ChildrenBrenton L G Button, Gina Martin, Andrew F Clark, et al.
JMIR Formative Research|September 11, 2025
A Youth-Centered Digital Infographic on Vaping Risks (What's in a Vape?): Mixed Methods StudyKendra Nelson Ferguson, Kyla Christianson, Adrian Delgado, et al.
International Journal of Environmental Research and Public Health|December 1, 2020
Measuring Temporal Differences in Rural Canadian Children's Moderate-to-Vigorous Physical ActivityBrenton L G Button, Andrew F Clark, Gina Martin, et al.
Journal of Drugs in Dermatology : JDD|January 28, 2020
Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 TrialsEmil A. Tanghetti, William P. Werschler, Terry Lain, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Journal of Drugs in Dermatology : JDD|June 24, 2020
New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric AnalysisLawrence F Eichenfield, Emil A Tanghetti, Eric Guenin, et al.
International Journal of Environmental Research and Public Health|August 26, 2022
Measurement Invariance of the WHO-5 Well-Being Index: Evidence from 15 European CountriesAlina Cosma, András Költő, Yekaterina Chzhen, et al.
The American Journal on Addictions|February 19, 2013
Alcohol and drug use as predictors of intentional injuries in two emergency departments in British ColumbiaCheryl J Cherpitel, Gina Martin, Scott Macdonald, et al.
Journal of Health Care for the Poor and Underserved|May 17, 2016
'Our only resource': Perspectives and Recommendations of Rural African American Youth on Adapting Sexual Health and Risk Reduction InterventionsRachel Hallum-Montes, Luella Rhodes, Cassandra Malone, et al.
Journal of Drugs in Dermatology : JDD|December 27, 2018
Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque PsoriasisLinda Stein Gold, Jerry Bagel, Mark Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|October 5, 2019
Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower ExtremitiesNeal D. Bhatia, Tracey C. Vlahovic, Lawrence G. Green, et al.
Children (Basel, Switzerland)|November 20, 2020
Examining Factors of Accelerometer-Measured Sedentary Time in a Sample of Rural Canadian ChildrenBrenton L G Button, Gina Martin, Andrew F Clark, et al.
JMIR Formative Research|September 11, 2025
A Youth-Centered Digital Infographic on Vaping Risks (What's in a Vape?): Mixed Methods StudyKendra Nelson Ferguson, Kyla Christianson, Adrian Delgado, et al.
International Journal of Environmental Research and Public Health|December 1, 2020
Measuring Temporal Differences in Rural Canadian Children's Moderate-to-Vigorous Physical ActivityBrenton L G Button, Andrew F Clark, Gina Martin, et al.
Journal of Drugs in Dermatology : JDD|January 28, 2020
Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 TrialsEmil A. Tanghetti, William P. Werschler, Terry Lain, et al.
Pageof 7